MAVIRET

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom

Active ingredients

The drug MAVIRET contains a combination of these active pharmaceutical ingredients (APIs):

1 Glecaprevir
UNII K6BUU8J72P - GLECAPREVIR
Read about Glecaprevir
2 Pibrentasvir
UNII 2WU922TK3L - PIBRENTASVIR

Pibrentasvir is a pan-genotypic inhibitor of HCV nonstructural protein 5A (NS5A), which is essential for viral RNA replication and virion assembly.

Read about Pibrentasvir

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
MAVIRET Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J05AP57 J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AP Antivirals for treatment of HCV infections
Discover more medicines within J05AP57

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 11332K, 11333L, 11337Q, 11344C, 11345D, 11346E, 11353M, 11354N, 11355P
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 543718050003302
Country: CA Health Products and Food Branch Identifier(s): 02467550
Country: EE Ravimiamet Identifier(s): 1751037, 1852860, 1860016
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 1171213001
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 071635, 436586
Country: FR Base de données publique des médicaments Identifier(s): 63052124
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 346924
Country: HK Department of Health Drug Office Identifier(s): 65653
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 8348
Country: JP 医薬品医療機器総合機構 Identifier(s): 6250113D1020, 6250113F1021
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1083656, 1093263
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 18901
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100392356, 100458876
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W65905001
Country: SG Health Sciences Authority Identifier(s): 15603P
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8680656080506

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.